Alembic Pharmaceuticals Ltd
NSE:APLLTD
Alembic Pharmaceuticals Ltd
NSE:APLLTD
Price:
764.05
INR
-0.45%
Market Closed
Market Cap:
₹150.2B
Cash Flow Statement
Cash Flow Statement
Alembic Pharmaceuticals Ltd
Alembic Pharmaceuticals Ltd
Currency: INR
| Mar-2020 | Sep-2020 | Mar-2021 | Sep-2021 | Mar-2022 | Sep-2022 | Mar-2023 | Sep-2023 | Mar-2024 | Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
9 998
|
12 998
|
13 681
|
9 930
|
6 201
|
3 301
|
3 546
|
5 262
|
6 318
|
7 049
|
7 072
|
7 836
|
|
| Depreciation & Amortization |
1 573
|
1 712
|
1 835
|
2 060
|
2 868
|
3 138
|
2 754
|
2 744
|
2 727
|
2 785
|
2 786
|
2 889
|
|
| Other Non-Cash Items |
1 210
|
734
|
(823)
|
(443)
|
1 363
|
2 649
|
2 122
|
507
|
142
|
735
|
950
|
1 223
|
|
| Cash Taxes Paid |
2 361
|
2 593
|
2 454
|
2 009
|
1 234
|
944
|
607
|
264
|
199
|
873
|
714
|
407
|
|
| Cash Interest Paid |
1 111
|
987
|
729
|
514
|
519
|
754
|
497
|
517
|
494
|
564
|
786
|
948
|
|
| Change in Working Capital |
(8 290)
|
(3 067)
|
(59)
|
(3 240)
|
(4 908)
|
(2 335)
|
(1 183)
|
(2 485)
|
(1 155)
|
(6 477)
|
(9 927)
|
(6 029)
|
|
| Cash from Operating Activities |
4 491
N/A
|
12 378
+176%
|
14 634
+18%
|
8 306
-43%
|
5 524
-33%
|
6 754
+22%
|
7 240
+7%
|
6 028
-17%
|
8 032
+33%
|
4 092
-49%
|
880
-79%
|
5 919
+573%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(7 349)
|
(6 168)
|
(6 595)
|
(6 542)
|
(4 256)
|
(3 858)
|
(4 434)
|
(3 985)
|
(3 275)
|
(3 281)
|
(5 636)
|
(6 612)
|
|
| Other Items |
33
|
37
|
(1 793)
|
(1 870)
|
537
|
517
|
(42)
|
165
|
69
|
(106)
|
(48)
|
(7)
|
|
| Cash from Investing Activities |
(7 316)
N/A
|
(6 131)
+16%
|
(8 388)
-37%
|
(8 412)
0%
|
(3 720)
+56%
|
(3 342)
+10%
|
(4 476)
-34%
|
(3 820)
+15%
|
(3 206)
+16%
|
(3 388)
-6%
|
(5 684)
-68%
|
(6 619)
-16%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
0
|
7 341
|
7 341
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
1 605
|
(3 308)
|
(3 980)
|
2 305
|
1 098
|
(1 767)
|
(172)
|
642
|
(2 312)
|
1 843
|
7 386
|
3 943
|
|
| Cash Paid for Dividends |
(3 260)
|
(2 010)
|
0
|
(2 752)
|
(2 752)
|
(1 966)
|
(1 966)
|
(1 572)
|
(1 573)
|
(2 162)
|
(2 162)
|
(2 162)
|
|
| Other |
3 203
|
(6 302)
|
(9 335)
|
(980)
|
(520)
|
(282)
|
(482)
|
(517)
|
(494)
|
(578)
|
(786)
|
(957)
|
|
| Cash from Financing Activities |
1 549
N/A
|
(4 278)
N/A
|
(5 974)
-40%
|
(1 427)
+76%
|
(2 174)
-52%
|
(4 015)
-85%
|
(2 620)
+35%
|
(1 447)
+45%
|
(4 379)
-203%
|
(897)
+80%
|
4 437
N/A
|
824
-81%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
4
|
(63)
|
(9)
|
57
|
0
|
2
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
(1 272)
N/A
|
1 906
N/A
|
263
-86%
|
(1 476)
N/A
|
(370)
+75%
|
(601)
-62%
|
144
N/A
|
760
+428%
|
447
-41%
|
(193)
N/A
|
(367)
-91%
|
123
N/A
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
(2 858)
N/A
|
6 210
N/A
|
8 039
+29%
|
1 764
-78%
|
1 268
-28%
|
2 896
+128%
|
2 806
-3%
|
2 043
-27%
|
4 757
+133%
|
811
-83%
|
(4 757)
N/A
|
(694)
+85%
|
|
Switch to:
Switch to:
See Also
Discover More
